» Articles » PMID: 35883846

Demethylation of H3K9 and H3K27 Contributes to the Tubular Renal Damage Triggered by Endoplasmic Reticulum Stress

Abstract

Loss of protein homeostasis (proteostasis) in the endoplasmic reticulum (ER) activates the unfolded protein response (UPR), restoring correct protein folding. Sustained ER stress exacerbates activation of the major UPR branches (IRE1α/XBP1, PERK/ATF4, ATF6), inducing expression of numerous genes involved in inflammation, cell death, autophagy, and oxidative stress. We investigated whether epigenetic dynamics mediated by histone H3K9 and H3K27 methylation might help to reduce or inhibit the exacerbated and maladaptive UPR triggered in tubular epithelial cells. Epigenetic treatments, specific silencing, and chromatin immunoprecipitation assays were performed in human proximal tubular cells subjected to ER stress. Pharmacological blockage of KDM4C and JMJD3 histone demethylases with SD-70 and GSKJ4, respectively, enhanced trimethylation of H3K9 and H3K27 in the and genes, inhibiting their expression and that of downstream genes. Conversely, specific G9a and EZH2 knockdown revealed increases in ATF4 and XBP1 expression. This is a consequence of the reduced recruitment of G9a and EZH2 histone methylases, diminished H3K9me3 and H3K27me3 levels, and enhanced histone acetylation at the and promoter region. G9a and EZH2 cooperate to maintain the repressive chromatin structure in both UPR-induced genes, ATF4 and XBP1. Therefore, preserving histone H3K9 and H3K27 methylation could ameliorate the ER stress, and consequently the oxidative stress and the triggered pathological processes that aggravate renal damage.

Citing Articles

GZ17-6.02 kills PDX isolates of uveal melanoma.

Booth L, Roberts J, Spasojevic I, Baker K, Poklepovic A, West C Oncotarget. 2024; 15:328-344.

PMID: 38758815 PMC: 11101052. DOI: 10.18632/oncotarget.28586.


Inhibition of BRD4 Attenuates ER Stress-induced Renal Ischemic-Reperfusion Injury.

Diaz-Bulnes P, Rodriguez R, Banon-Maneus E, Saiz M, Bernet C, Corte-Iglesias V Int J Biol Sci. 2024; 20(5):1547-1562.

PMID: 38481808 PMC: 10929187. DOI: 10.7150/ijbs.83040.


Functioning and mechanisms of PTMs in renal diseases.

Liu Z, Yang J, Du M, Xin W Front Pharmacol. 2023; 14:1238706.

PMID: 38074159 PMC: 10702752. DOI: 10.3389/fphar.2023.1238706.


Research progress on endoplasmic reticulum homeostasis in kidney diseases.

Wu D, Huang L, Chen X, Huang X, Li H, An N Cell Death Dis. 2023; 14(7):473.

PMID: 37500613 PMC: 10374544. DOI: 10.1038/s41419-023-05905-x.


Loss of renal tubular G9a benefits acute kidney injury by lowering focal lipid accumulation via CES1.

Yang D, Fan Y, Xiong M, Chen Y, Zhou Y, Liu X EMBO Rep. 2023; 24(6):e56128.

PMID: 37042626 PMC: 10240209. DOI: 10.15252/embr.202256128.


References
1.
Zhang N, Shang M, Li H, Wu L, Dong M, Huang B . Dual Inhibition of H3K9me2 and H3K27me3 Promotes Tumor Cell Senescence without Triggering the Secretion of SASP. Int J Mol Sci. 2022; 23(7). PMC: 8999616. DOI: 10.3390/ijms23073911. View

2.
Gu Y, Huang F, Wang Y, Chen C, Wu S, Zhou S . Connexin32 plays a crucial role in ROS-mediated endoplasmic reticulum stress apoptosis signaling pathway in ischemia reperfusion-induced acute kidney injury. J Transl Med. 2018; 16(1):117. PMC: 5935959. DOI: 10.1186/s12967-018-1493-8. View

3.
Bujisic B, de Gassart A, Tallant R, Demaria O, Zaffalon L, Chelbi S . Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth. Blood. 2017; 129(17):2420-2428. DOI: 10.1182/blood-2016-09-741348. View

4.
Liu H, Wang L, Weng X, Chen H, Du Y, Diao C . Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress. Redox Biol. 2019; 24:101195. PMC: 6475721. DOI: 10.1016/j.redox.2019.101195. View

5.
Liu H, Wang W, Weng X, Chen H, Chen Z, Du Y . The H3K9 histone methyltransferase G9a modulates renal ischemia reperfusion injury by targeting Sirt1. Free Radic Biol Med. 2021; 172:123-135. DOI: 10.1016/j.freeradbiomed.2021.06.002. View